PPARPromotes Growth and Invasion of Thyroid Cancer Cells
Open Access
- 12 December 2011
- journal article
- research article
- Published by Wiley in PPAR Research
- Vol. 2011, 1-11
Abstract
Undifferentiated (anaplastic) thyroid cancer (ATC) is one of the most aggressive human malignancies and no effective therapy is currently available. We show here that PPARγlevels are elevated in cells derived from ATC. Depletion of PPARγin HTh74 ATC cells resulted in decreased cell growth, cell cycle arrest and a reduction in pRb and cyclin A and B1 levels. We further showed that both flank and orthotopic thyroid tumors derived from PPARγ-depleted cells grew more slowly than PPARγ-expressing cells. When PPARγwas overexpressed in more differentiated thyroid cancer BCPAP cells which lack PPARγ, there was increased growth and raised pRb and cyclin A and B1 levels. Finally, PPARγdepletion in ATC cells decreased their invasive capacity whereas overexpression in PTC cells increased invasiveness. These data suggest that PPARγmay play a detrimental role in thyroid cancer and that targeting it therapeutically may lead to improved treatment of advanced thyroid cancer.Keywords
Funding Information
- National Cancer Institute (R01 CA100560)
- Mary Rossick Kern and Jerome H. Kern Endowment for Endocrine Neoplasms Research (R01 CA100560)
This publication has 42 references indexed in Scilit:
- The Putative PAX8/PPAR Fusion Oncoprotein Exhibits Partial Tumor Suppressor Activity through Up-Regulation of Micro-RNA-122 and Dominant-Negative PPAR ActivityGenes & Cancer, 2011
- PPARγ-independent antitumor effects of thiazolidinedionesCancer Letters, 2009
- Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer GrowthCancer Research, 2009
- Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expressionMolecular Cancer, 2009
- Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and MisidentificationThe Journal of Clinical Endocrinology & Metabolism, 2008
- Inhibition of cell motility by troglitazone in human ovarian carcinoma cell lineBMC Cancer, 2007
- PPARγ insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-κB signaling pathwayOncogene, 2005
- Evaluation of Peroxisome Proliferator-Activated Receptor-γ Expression in Benign and Malignant Thyroid PathologiesThyroid®, 2005
- Effect of peroxisome proliferator-activated receptor γ agonist, rosiglitazone, on dedifferentiated thyroid cancersNuclear Medicine Communications, 2004
- PPARγ signaling exacerbates mammary gland tumor developmentGenes & Development, 2004